Clinical Trial: Phase 2b Study of ALTO-100 in MDD
Study Status: Completed
Recruit Status: RECRUITING
Condition: Major Depressive Disorder
Study Type: INTERVENTIONAL
Official Title: A Randomized, Double-Blind, Placebo-Controlled Study of ALTO-100 With an Open-Label Extension in Adults With Major Depressive Disorder
Brief Summary:
The purpose of this study is to determine efficacy differences between ALTO-100 and placebo, used either as monotherapy or adjunctively to an antidepressant, related to patient characteristics.
Read more